Breaks Categories: News

ThursdaySep 29, 2022 1:02 pm

NetworkNewsBreaks – IBN Announces Collaboration for Upcoming DX3 USA Summit

IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content distributor, today announced that its NetworkNewsWire (“NNW”) brand was engaged by DX3, IoT Events and Web3Toronto as the official newswire for the upcoming DX3 USA Retail, Marketing & Technology Summit (“DX3 USA”). IBN will also serve as the corporate communications firm for the summit, slated to be held in a virtual format on Oct. 3-4, 2022. In its capacity as the official newswire, NNW will combine traditional wire-grade press release dissemination with article syndication. IBN, as the event’s corporate communications firm, will leverage its array of state-of-the-art solutions to heighten the…

Continue Reading

ThursdaySep 29, 2022 12:36 pm

NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing Requirements

Aditxt (NASDAQ: ADTX) is a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system. The company today announced its receipt of confirmation from the Nasdaq Stock Market LLC Hearing Panel that it has regained compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2). In addition, Nasdaq confirmed that Aditxt meets the stockholders’ equity requirement in Listing Rule 5550(b)(1) and all other applicable criteria for continued listing. Amro Albanna, co-founder, chairman and CEO of Aditxt, said that the company’s recent completion of a reverse stock split…

Continue Reading

ThursdaySep 29, 2022 12:28 pm

NetworkNewsBreaks – BlockQuarry Corp. (BLQC) Releases Corporate Update, Financial Highlights

BlockQuarry (OTC: BLQC), a Texas-based company with commercial-stage operations in cryptocurrency mine hosting and self-mining in the southeast United States, is providing shareholders with provisional and unaudited Q3 performance projections along with highlights from its financial performance for the three months ended June 30, 2022. According to the update, BLQC management anticipates that the company is “on pace” for top-line sequential quarterly growth of some 30% during the three months ending Sept. 30, 2022. In addition, the update noted that for the three months ended June 30, 2022, revenue was up almost 8,000% year over year, totaled more than $1.5…

Continue Reading

ThursdaySep 29, 2022 11:01 am

NetworkNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) KWC Expands Insurance Coverage with Medicare for Ketamine Therapy Patients

Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), has become one of a few U.S.-based ketamine therapy providers to offer Medicare coverage to patients at eight KWC clinics across the country. Under Medicare, KWC is accepting a limited number of patients for ketamine infusion therapy at Chicago, Denver, Houston, Jacksonville, Minneapolis, Tucson, Salt Lake City and Seattle clinics. In addition, KWC is providing the FDA-approved SPRAVATO(R) esketamine treatment at Houston, Jacksonville and Seattle locations for patients meeting the criteria for insurance coverage. “At Ketamine…

Continue Reading

ThursdaySep 29, 2022 10:27 am

NetworkNewsBreaks – Grapefruit USA Inc. (GPFT) Enters Strategic Partnership with Rob Van Dam, Continues to Capitalize on Cannabis 3.0

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company and cannabis distributor, today announced its entry into an exclusive licensing agreement with WWE Hall of Fame wrestler and cannabis pioneer Rob Van Dam to bring his branded cannabis products to the California retail marketplace. “Our industry has matured over the past several years, and that maturation has fundamentally focused success in the retail marketplace around effective product branding. There is a lot of competition for product shelf space in retail stores. Retailers look to the brands that are likely to generate the most sales, and the well-known cannabis brands are…

Continue Reading

ThursdaySep 29, 2022 10:22 am

NetworkNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces $10K Donation to the American Cancer Society

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company that delivers unique player experiences across a variety of genres, will donate $10,000 to the American Cancer Society; the company is making the donation in honor of Breast Cancer Awareness Month, which begins on Oct. 1. Millions of fans around the world play DoubleDown Casino every day, and the company will encourage its players to support the cause by participating in a play-to-enter giveaway called Spin for Cures. Whether they’re playing on their desktop or mobile devices, players will be able to contribute to the cause and learn more about what the…

Continue Reading

ThursdaySep 29, 2022 10:16 am

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Shares Info about New Sport Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is providing a first look at its newest upcoming vehicle offering. The company released information about the FIVE RS, an ultrahigh-performance EV sport crossover. According to the announcement, Mullen’s newest EV can go from 0 to 60 mph in 1.9 seconds and comes with all-wheel drive, a two-speed gearbox, 800-volt architecture and 1,000-plus horsepower. Mullen plans to feature the FIVE RS in the second leg of its test-drive tour, beginning in April. Because of the vehicle’s high-powered capabilities, potential buyers won’t be able to test drive the vehicle; however, they…

Continue Reading

WednesdaySep 28, 2022 3:04 pm

NetworkNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Results from Annual Meeting

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced voting results in connection with the annual and special meeting of the company's shareholders, which was held virtually on Sept. 27, 2022. According to the announcement, a total of 31,830,069 common shares representing 45.55% of the company’s issued and outstanding common shares were voted in connection with the meeting. Shareholders voted in favor of the election of the six director nominees as well as other items of business, including the re-appointment of RSM Canada LLP as the company’s auditors, the adoption of new company by-laws, and the approval of the…

Continue Reading

WednesdaySep 28, 2022 2:09 pm

NetworkNewsBreaks – Lift&Co. Expo 2023 to Showcase 130+ Expert Speakers and Exclusive Educational Content

Lift&Co. Expo, Canada’s no. 1 cannabis conference and trade show, is set to return to the Vancouver Convention Centre in Vancouver, British Columbia, on Jan. 12-14, 2023. The premier event for seasoned professionals, recreational and medical consumers, industry associations, sectoral pioneers, dedicated media, and specialist investors engaged in the cannabis sector will feature more than 130 expert speakers. In addition, various sessions will showcase exclusive educational content, including presentations and panel discussions that shed light on the opportunities and day-to-day challenges across every facet of the Canadian cannabis business sector. The agenda will shed light on key topics, including trends…

Continue Reading

WednesdaySep 28, 2022 2:05 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Activates First European Sites for Potentially Pivotal Clinical Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. According to the update, the first European clinical trial sites in France and Spain are now open and actively enrolling patients. “Our primary focus continues to be on advancing the clinical development of…

Continue Reading